<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Morphology</journal-id><journal-title-group><journal-title xml:lang="en">Morphology</journal-title><trans-title-group xml:lang="ru"><trans-title>Морфология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1026-3543</issn><issn publication-format="electronic">2949-2556</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">629463</article-id><article-id pub-id-type="doi">10.17816/morph.629463</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Regulatory role of protein p53 in the functional activity of the central nervous system</article-title><trans-title-group xml:lang="ru"><trans-title>Регуляторная роль белка р53 в функциональной активности центральной нервной системы</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8416-8238</contrib-id><name-alternatives><name xml:lang="en"><surname>Kotov</surname><given-names>Vladislav N.</given-names></name><name xml:lang="ru"><surname>Котов</surname><given-names>Владислав Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>fnkc.vladislav@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5182-0373</contrib-id><contrib-id contrib-id-type="spin">4364-3214</contrib-id><name-alternatives><name xml:lang="en"><surname>Kostyaeva</surname><given-names>Margarita G.</given-names></name><name xml:lang="ru"><surname>Костяева</surname><given-names>Маргарита Гурьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Veterinary), Assistant Professor</p></bio><bio xml:lang="ru"><p>канд. ветеринар. наук, доцент</p></bio><email>kostyaeva.71@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ibadullaeva</surname><given-names>Svetlana S.</given-names></name><name xml:lang="ru"><surname>Ибадуллаева</surname><given-names>Светлана Сулеймановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ibadullayeva00@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5766-9416</contrib-id><contrib-id contrib-id-type="spin">2765-7044</contrib-id><name-alternatives><name xml:lang="en"><surname>Ganshin</surname><given-names>Igor B.</given-names></name><name xml:lang="ru"><surname>Ганьшин</surname><given-names>Игорь Борисович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>gibdoc@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6014-4597</contrib-id><contrib-id contrib-id-type="spin">8907-1850</contrib-id><name-alternatives><name xml:lang="en"><surname>Khodorovich</surname><given-names>Olga S.</given-names></name><name xml:lang="ru"><surname>Ходорович</surname><given-names>Ольга Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>khodorovich-o@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1469-2365</contrib-id><contrib-id contrib-id-type="spin">9802-8610</contrib-id><name-alternatives><name xml:lang="en"><surname>Valiev</surname><given-names>Timur T.</given-names></name><name xml:lang="ru"><surname>Валиев</surname><given-names>Тимур Теймуразович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>timurvaliev@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8533-301X</contrib-id><contrib-id contrib-id-type="spin">5814-9282</contrib-id><name-alternatives><name xml:lang="en"><surname>Kartasheva</surname><given-names>Alla F.</given-names></name><name xml:lang="ru"><surname>Карташева</surname><given-names>Алла Федоровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>khodorovich-o@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples' Friendship University of Russia named after Patrice Lumumba</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов им. Патриса Лумумбы</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National Medical Research Center of Oncology named after N.N. Blokhin</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-06-18" publication-format="electronic"><day>18</day><month>06</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2023</year></pub-date><volume>161</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>113</fpage><lpage>128</lpage><history><date date-type="received" iso-8601-date="2024-03-27"><day>27</day><month>03</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-05-24"><day>24</day><month>05</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2023,</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-10-15"/></permissions><self-uri xlink:href="https://j-morphology.com/1026-3543/article/view/629463">https://j-morphology.com/1026-3543/article/view/629463</self-uri><abstract xml:lang="en"><p>Protein p53 is one of the most popular topics among researchers. Over the past 40 years since its discovery, more than 100 thousand scientific works have been written, and this is growing steadily. The increased interest in this protein among doctors lies in its participation in the development of malignant tumors, a socially significant group of diseases of the 21<sup>st </sup>century. p53 is a tumor suppressor. Normally, when exposed to damaging factors, this protein promotes DNA repair or apoptosis, depending on the damage, which in turn prevents the accumulation of cells with mutant DNAs. When p53 mutates, it loses its function, leading to abnormal cell proliferation and tumor progression.</p> <p>The role of p53 is not limited to carcinogenesis. It also participates in the regulation of the central nervous system; however, its role is ambiguous. Although p53 is also involved in the embryogenesis of nervous tissue and promotes the differentiation of neural stem cells, it can also have a damaging effect on neurons.</p> <p>The literature review presents current data on the structure and function of p53, the main regulator of the human genome, and its homologs (p63 and p73). These proteins are considered to play a role in programmed cell death and carcinogenesis. The role of p53 family proteins in the functioning of the central nervous system and neuroprotection was also examined.</p></abstract><trans-abstract xml:lang="ru"><p>Белок р53 является одним из наиболее популярных объектов исследований среди учёных. За последние 40 лет с момента его открытия было написано более 100 тыс. научных работ, и их число продолжает неуклонно расти. Повышенный интерес к данному белку среди врачей обусловлен участием р53 в развитии злокачественных новообразований — социально значимой группы заболеваний XXI века. Белок р53 является супрессором опухолевого роста. В норме при воздействии повреждающих факторов он способствует репарации ДНК или апоптозу, в зависимости от повреждения, что в свою очередь препятствует накоплению клеток с мутантной ДНК. Когда р53 мутирует, он теряет свою функцию, а это приводит к аномальной пролиферации клеток и прогрессированию опухоли.</p> <p>Роль р53 не ограничивается только участием в канцерогенезе. Другой не менее важной и интересной функцией является участие данного белка в регуляции деятельности центральной нервной системы, однако роль его в этом неоднозначна. С одной стороны, р53 участвует в эмбриогенезе нервной ткани и способствует дифференцировке нейральных стволовых клеток, с другой стороны, он может оказывать и повреждающее действие на нейроны.</p> <p>В обзоре представлены современные данные о структуре и функции главного регулятора генома человека — белка р53 — и его гомологов р63 и р73. Рассмотрено участие данных белков в запрограммированной клеточной гибели и в канцерогенезе. Отдельное внимание уделено роли белков семейства р53 в функционировании клеток центральной нервной системы и нейропротекции.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>p53</kwd><kwd>apoptosis</kwd><kwd>cancerogenesis</kwd><kwd>tumors</kwd><kwd>neuroprotection</kwd><kwd>neurodegenerative diseases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>р53</kwd><kwd>апоптоз</kwd><kwd>канцерогенез</kwd><kwd>опухоли</kwd><kwd>нейропротекция</kwd><kwd>нейродегенеративные заболевания</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979;278(5701):261–263. doi: 10.1038/278261a0</mixed-citation><mixed-citation xml:lang="ru">Lane D.P., Crawford L. V. T antigen is bound to a host protein in SV40-transformed cells // Nature. 1979. Vol. 278, N 5701. P. 261–263. doi: 10.1038/278261a0</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22(2):127–144. doi: 10.1038/s41573-022-00571-8</mixed-citation><mixed-citation xml:lang="ru">Hassin O., Oren M. Drugging p53 in cancer: one protein, many targets // Nat Rev Drug Discov. 2023. Vol. 22, N 2. P. 127–144. doi: 10.1038/s41573-022-00571-8</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Zierhut C. p53 and innate immune signaling in development and cancer: insights from a hematologic model of genome instability. Cancer Res. 2023;83(17):2807–2808. doi: 10.1158/0008-5472.CAN-23-1855</mixed-citation><mixed-citation xml:lang="ru">Zierhut C. p53 and innate immune signaling in development and cancer: insights from a hematologic model of genome instability // Cancer Res. 2023. Vol. 83, N 17. P. 2807–2808. doi: 10.1158/0008-5472.CAN-23-1855</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Firestein GS, Echeverri F, Yeo M, et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A. 1997;94(20):10895–10900. doi: 10.1073/pnas.94.20.10895</mixed-citation><mixed-citation xml:lang="ru">Firestein G.S., Echeverri F., Yeo M., et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium // Proc Natl Acad Sci U S A. 1997. Vol. 94, N 20. P. 10895–10900. doi: 10.1073/pnas.94.20.10895</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Yamanishi Y, Boyle DL, Rosengren S, et al. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A. 2002;99(15):10025–10030. doi: 10.1073/pnas.152333199</mixed-citation><mixed-citation xml:lang="ru">Yamanishi Y., Boyle D. L., Rosengren S., et al. Regional analysis of p53 mutations in rheumatoid arthritis synovium // Proc Natl Acad Sci U S A. 2002. Vol. 99, N 15. P. 10025–10030. doi: 10.1073/pnas.152333199</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Kostyaeva MG, Popadyuk VI, Kastyro IV, et al. Significance of simulation of septoplasty in rats as a factor of surgical stress in p53 protein expression and its functional role in hippocampal pyramidal neurons. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2023;29(2):58–68. EDN: XQMJIH doi: 10.33848/foliorl23103825-2023-29-2-58-68</mixed-citation><mixed-citation xml:lang="ru">Костяева М.Г., Попадюк В. И., Кастыро И. В., и др. Значение моделирования септопластики у крыс как фактора хирургического стресса в экспрессии белка p53 и его функциональной роли в пирамидных нейронах гиппокампа // Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2023. Т. 29, № 2. С. 58–68. EDN: XQMJIH doi: 10.33848/foliorl23103825-2023-29-2-58-68</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Drozdova G, Kastyro I, Khamidulin G, et al. The effect of stress on the formation of p53-positive and dark neurons in the hippocampus in a model of septoplasty in rats. Journal of Clinical Physiology and Pathology. 2022;1(1):35–45.</mixed-citation><mixed-citation xml:lang="ru">Drozdova G., Kastyro I., Khamidulin G., et al. The effect of stress on the formation of p53-positive and dark neurons in the hippocampus in a model of septoplasty in rats // Journal of Clinical Physiology and Pathology. 2022. Vol. 1, N 1. P. 35–45.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Donehower LA, Soussi T, Korkut A, et al. Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas. Cell Rep. 2019;28(5):1370–1384.e5. Corrected and republished from: Cell Rep. 2019 Sep 10;28(11):3010. doi: 10.1016/j.celrep.2019.07.001</mixed-citation><mixed-citation xml:lang="ru">Donehower L.A., Soussi T., Korkut A., et al. Integrated analysis of TP53 gene and pathway alterations in The Cancer Genome Atlas // Cell Rep. 2019. Vol. 28, N 5. P. 1370–1384. Corrected and republished from: Cell Rep. 2019. Vol. 28, N 11. P. 3010. doi: 10.1016/j.celrep.2019.07.001</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413–431. doi: 10.1016/j.cell.2009.04.037</mixed-citation><mixed-citation xml:lang="ru">Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53 // Cell. 2009. Vol. 137, N 3. P. 413–431. doi: 10.1016/j.cell.2009.04.037</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13(6):1027–1036. doi: 10.1038/sj.cdd.4401910</mixed-citation><mixed-citation xml:lang="ru">Levine A.J., Hu W., Feng Z. The P53 pathway: what questions remain to be explored? // Cell Death Differ. 2006. Vol. 13, N 6. P. 1027–1036. doi: 10.1038/sj.cdd.4401910</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Aubrey BJ, Kelly GL, Janic A, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25(1):104–113. doi: 10.1038/cdd.2017.169</mixed-citation><mixed-citation xml:lang="ru">Aubrey B.J., Kelly G. L., Janic A., et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? // Cell Death Differ. 2018. Vol. 25, N 1. P. 104–113. doi: 10.1038/cdd.2017.169</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Williams AB, Schumacher B. p53 in the DNA-damage-repair process. Cold Spring Harb Perspect Med. 2016;6(5):a026070. doi: 10.1101/cshperspect.a026070</mixed-citation><mixed-citation xml:lang="ru">Williams A.B., Schumacher B. p53 in the DNA-damage-repair process // Cold Spring Harb Perspect Med. 2016. Vol. 6, N 5. P. a026070. doi: 10.1101/cshperspect.a026070</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14(5):359–370. doi: 10.1038/nrc3711</mixed-citation><mixed-citation xml:lang="ru">Bieging K.T., Mello S. S., Attardi L. D. Unravelling mechanisms of p53-mediated tumour suppression // Nat Rev Cancer. 2014. Vol. 14, N 5. P. 359–370. doi: 10.1038/nrc3711</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Sciot R. MDM2 amplified sarcomas: a literature review. Diagnostics (Basel). 2021;11(3):496. doi: 10.3390/diagnostics11030496</mixed-citation><mixed-citation xml:lang="ru">Sciot R. MDM2 Amplified sarcomas: a literature review // Diagnostics (Basel). 2021. Vol. 11, N 3. P. 496. doi: 10.3390/diagnostics11030496</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 1995;378(6553):203–206. doi: 10.1038/378203a0</mixed-citation><mixed-citation xml:lang="ru">Montes de Oca Luna R., Wagner D. S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 // Nature. 1995. Vol. 378, N 6553. P. 203–206. doi: 10.1038/378203a0</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Momand J, Wu HH, Dasgupta G. MDM2 — master regulator of the p53 tumor suppressor protein. Gene. 2000;242(1–2):15–29. doi: 10.1016/s0378-1119(99)00487-4</mixed-citation><mixed-citation xml:lang="ru">Momand J., Wu H. H., Dasgupta G. MDM2 — master regulator of the p53 tumor suppressor protein // Gene. 2000. Vol. 242(1–2). P. 15–29. doi: 10.1016/s0378-1119(99)00487-4</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2(3):305–316. doi: 10.1016/s1097-2765(00)80275-0</mixed-citation><mixed-citation xml:lang="ru">Yang A., Kaghad M., Wang Y., et al. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities // Mol Cell. 1998. Vol. 2, N 3. P. 305–316. doi: 10.1016/s1097-2765(00)80275-0</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997;90(4):809–819. doi: 10.1016/s0092-8674(00)80540-1</mixed-citation><mixed-citation xml:lang="ru">Kaghad M., Bonnet H., Yang A., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers // Cell. 1997. Vol. 90, N 4. P. 809–819. doi: 10.1016/s0092-8674(00)80540-1</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Leong CO, Vidnovic N, DeYoung MP, et al. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest. 2007;117(5):1370–1380. doi: 10.1172/JCI30866</mixed-citation><mixed-citation xml:lang="ru">Leong C.O., Vidnovic N., DeYoung M.P., et al. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers // J Clin Invest. 2007. Vol. 117, N 5. P. 1370–1380. doi: 10.1172/JCI30866</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Levrero M, De Laurenzi V, Costanzo A, et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci. 2000;113 (Pt 10):1661–1670. doi: 10.1242/jcs.113.10.1661</mixed-citation><mixed-citation xml:lang="ru">Levrero M., De Laurenzi V., Costanzo A., et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions // J Cell Sci. 2000. Vol. 113 (Pt 10). P. 1661–1670. doi: 10.1242/jcs.113.10.1661</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Kostyaeva MG, Dragunova SG, Shilin SS, et al. Modeling of rhinosurgical procedure in rats: expression of p53 protein and formation of dark neurons in the hippocampus. Head and neck. Russian Journal. 2022;10(S2S2):28–34. EDN: AMZRKJ doi: 10.25792/HN.2022.10.2.S2.28-34</mixed-citation><mixed-citation xml:lang="ru">Костяева М.Г., Драгунова С. Г., Шилин С. С., и др. Моделирование ринохирургических вмешательств у крыс: экспрессия белка р53 и формирование темных нейронов в гиппокампе. Head and Neck / Голова и шея. Российское издание. Журнал Общероссийской общественной организации «Федерация специалистов по лечению заболеваний головы и шеи». 2022. Т. 10, № S2S2. С. 28–34. EDN: AMZRKJ doi: 10.25792/HN.2022.10.2.S2.28-34</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Kostyaeva MG, Kastyro IV, Yunusov TYu, et al. Protein p53 expression and dark neurons in rat hippocampus after experimental septoplasty simulation. Molecular Genetics, Microbiology and Virology. 2022;37(1):19–24. doi: 10.3103/S0891416822010037</mixed-citation><mixed-citation xml:lang="ru">Kostyaeva M.G., Kastyro I. V., Yunusov T.Yu., et al. Protein p53 expression and dark neurons in rat hippocampus after experimental septoplasty simulation // Molecular Genetics, Microbiology and Virology. 2022. Vol. 37, N 1. P. 19–24. doi: 10.3103/S0891416822010037</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398(6729):708–713. doi: 10.1038/19531</mixed-citation><mixed-citation xml:lang="ru">Mills A.A., Zheng B., Wang X. J., et al. p63 is a p53 homologue required for limb and epidermal morphogenesis // Nature. 1999. Vol. 398, N 6729. P. 708–713. doi: 10.1038/19531</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8(4):603–619. doi: 10.18632/aging.100934.</mixed-citation><mixed-citation xml:lang="ru">Pistritto G., Trisciuoglio D., Ceci C., et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies // Aging (Albany NY). 2016. Vol. 8, N 4. P. 603–619. doi: 10.18632/aging.100934</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Kerr JF, Harmon BV. In: Apoptosis: the molecular basis of cell death. Tomei LD, Cope FO, editors. Vol. 3. New York: Cold Spring Harbor Laboratory Press; 1991. P. 5–29.</mixed-citation><mixed-citation xml:lang="ru">Kerr J.F., Harmon B. V. Programmed cell death and apoptosis. In: Apoptosis: the molecular basis of cell death. Tomei L. D., Cope F. O., editors. Vol. 3. New York: Cold Spring Harbor Laboratory Press, 1991. P. 5–29.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–257. doi: 10.1038/bjc.1972.33</mixed-citation><mixed-citation xml:lang="ru">Kerr J.F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics // Br J Cancer. 1972. Vol. 26, N 4. P. 239–257. doi: 10.1038/bjc.1972.33</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30(1):87. doi: 10.1186/1756-9966-30-87</mixed-citation><mixed-citation xml:lang="ru">Wong R. S. Apoptosis in cancer: from pathogenesis to treatment // J Exp Clin Cancer Res. 2011. Vol. 30, N 1. P. 87. doi: 10.1186/1756-9966-30-87</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23(6):1625–1637. doi: 10.1096/fj.08-111005</mixed-citation><mixed-citation xml:lang="ru">Guicciardi M.E., Gores G. J. Life and death by death receptors // FASEB J. 2009. Vol. 23, N 6. P. 1625–1637. doi: 10.1096/fj.08-111005</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol. 2003;15(6):725–731. doi: 10.1016/j.ceb.2003.10.009</mixed-citation><mixed-citation xml:lang="ru">Boatright K.M., Salvesen G. S. Mechanisms of caspase activation // Curr Opin Cell Biol. 2003. Vol. 15, N 6. P. 725–731. doi: 10.1016/j.ceb.2003.10.009</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87(1):99–163. doi: 10.1152/physrev.00013.2006</mixed-citation><mixed-citation xml:lang="ru">Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death // Physiol Rev. 2007. Vol. 87, N 1. P. 99–163. doi: 10.1152/physrev.00013.2006</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116(2):205–219. doi: 10.1016/s0092-8674(04)00046-7</mixed-citation><mixed-citation xml:lang="ru">Danial N.N., Korsmeyer S. J. Cell death: critical control points // Cell. 2004. Vol. 116, N 2. P. 205–219. doi: 10.1016/s0092-8674(04)00046-7</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Slee EA, Adrain C, Martin SJ. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 1999;6(11):1067–1074. doi: 10.1038/sj.cdd.4400601</mixed-citation><mixed-citation xml:lang="ru">Slee E.A., Adrain C., Martin S. J. Serial killers: ordering caspase activation events in apoptosis // Cell Death Differ. 1999. Vol. 6, N 11. P. 1067–1074. doi: 10.1038/sj.cdd.4400601</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity. 2005;22(3):355–370. d oi: 10.1016/j.immuni.2005.02.004</mixed-citation><mixed-citation xml:lang="ru">Martinvalet D., Zhu P., Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis // Immunity. 2005. Vol. 22, N 3. P. 355–370. doi: 10.1016/j.immuni.2005.02.004</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2:647–56.</mixed-citation><mixed-citation xml:lang="ru">Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch // Nat Rev Cancer. 2002;2:647–656. doi: 10.1042/bst0290684</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Yu J, Zhang L. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell. 2003;4(4):248–249. doi: 10.1016/s1535-6108(03)00249-6</mixed-citation><mixed-citation xml:lang="ru">Yu J., Zhang L. No PUMA, no death: implications for p53-dependent apoptosis // Cancer Cell. 2003. Vol. 4, N 4. P. 248–249. doi: 10.1016/s1535-6108(03)00249-6</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Liu FT, Newland AC, Jia L. Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia. Biochem Biophys Res Commun. 2003;310(3):956–962. doi: 10.1016/j.bbrc.2003.09.109</mixed-citation><mixed-citation xml:lang="ru">Liu F.T., Newland A. C., Jia L. Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia // Biochem Biophys Res Commun. 2003. Vol. 310, N 3. P. 956–962. doi: 10.1016/j.bbrc.2003.09.109</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000;288(5468):1053–1058. doi: 10.1126/science.288.5468.1053</mixed-citation><mixed-citation xml:lang="ru">Oda E., Ohki R., Murasawa H., et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis // Science. 2000. Vol. 288, N 5468. P. 1053–1058. doi: 10.1126/science.288.5468.1053</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Harman D. Role of free radicals in aging and disease. Ann N Y Acad Sci. 1992;673:126–141. doi: 10.1111/j.1749–6632.1992.tb27444.x</mixed-citation><mixed-citation xml:lang="ru">Harman D. Role of free radicals in aging and disease // Ann N Y Acad Sci. 1992. Vol. 673. P. 126–141. doi: 10.1111/j.1749-6632.1992.tb27444.x</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">D’Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582–592. doi: 10.1002/cbin.11137</mixed-citation><mixed-citation xml:lang="ru">D’Arcy M. S. Cell death: a review of the major forms of apoptosis, necrosis and autophagy // Cell Biol Int. 2019. Vol. 43, N 6. P. 582–592. doi: 10.1002/cbin.11137</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Burns TF, El-Deiry WS. The p53 pathway and apoptosis. J Cell Physiol. 1999;181(2):231–239. doi: 10.1002/(SICI)1097-4652(199911)181:2&lt;231::AID-JCP5&gt;3.0.CO;2-L</mixed-citation><mixed-citation xml:lang="ru">Burns T.F., El-Deiry W. S. The p53 pathway and apoptosis // J Cell Physiol. 1999. Vol. 181, N 2. P. 231–239. doi: 10.1002/(SICI)1097-4652(199911)181:2&lt;231::AID-JCP5&gt;3.0.CO;2-L</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Carson DA, Lois A. Cancer progression and p53. Lancet. 1995;346(8981):1009–1011. doi: 10.1016/s0140-6736(95)91693-8</mixed-citation><mixed-citation xml:lang="ru">Carson D.A., Lois A. Cancer progression and p53 // Lancet. 1995. Vol. 346, N 8981. P. 1009–1011. doi: 10.1016/s0140-6736(95)91693-8</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang C, Liu J, Xu D, et al. Gain-of-function mutant p53 in cancer progression and therapy. J Mol Cell Biol. 2020;12(9):674–687. doi: 10.1093/jmcb/mjaa040</mixed-citation><mixed-citation xml:lang="ru">Zhang C., Liu J., Xu D., et al. Gain-of-function mutant p53 in cancer progression and therapy // J Mol Cell Biol. 2020. Vol. 12, N 9. P. 674–687. doi: 10.1093/jmcb/mjaa040</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Chen LL, Wang WJ. p53 regulates lipid metabolism in cancer. Int J Biol Macromol. 2021;192:45–54. doi: 10.1016/j.ijbiomac.2021.09.188</mixed-citation><mixed-citation xml:lang="ru">Chen L.L., Wang W. J. p53 regulates lipid metabolism in cancer // Int J Biol Macromol. 2021. Vol. 192. P. 45–54. doi: 10.1016/j.ijbiomac.2021.09.188</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 2022;85:4–32. doi: 10.1016/j.semcancer.2021.03.010</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression // Semin Cancer Biol. 2022. Vol. 85. P. 4–32. doi: 10.1016/j.semcancer.2021.03.010</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218. Corrected and republished from: Trends Biochem Sci. 2016;41(3):287. doi: 10.1016/j.tibs.2015.12.001</mixed-citation><mixed-citation xml:lang="ru">Liberti M.V., Locasale J. W. The Warburg effect: how does it benefit cancer cells? // Trends Biochem Sci. 2016. Vol. 41, N 3. P. 211–218. Corrected and republished from: Trends Biochem Sci. 2016. Vol. 41, N 3. P. 287. doi: 10.1016/j.tibs.2015.12.001</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004;64(7):2627–2633. doi: 10.1158/0008-5472.can-03-0846</mixed-citation><mixed-citation xml:lang="ru">Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression // Cancer Res. 2004. Vol. 64, N 7. P. 2627–2633. doi: 10.1158/0008-5472.can-03-0846</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Xi Y, Zhang Y, Pan J, et al. Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes. Toxicol Lett. 2020;318:1–11. doi: 10.1016/j.toxlet.2019.10.001</mixed-citation><mixed-citation xml:lang="ru">Xi Y., Zhang Y., Pan J., et al. Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes // Toxicol Lett. 2020. Vol. 318. P. 1–11. doi: 10.1016/j.toxlet.2019.10.001</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Yu G, Luo H, Zhang N, et al. Loss of p53 sensitizes cells to palmitic acid-induced apoptosis by reactive oxygen species accumulation. Int J Mol Sci. 2019;20(24):6268. doi: 10.3390/ijms20246268</mixed-citation><mixed-citation xml:lang="ru">Yu G., Luo H., Zhang N., et al. Loss of p53 sensitizes cells to palmitic acid-induced apoptosis by reactive oxygen species accumulation // Int J Mol Sci. 2019. Vol. 20, N 24. P. 6268. doi: 10.3390/ijms20246268</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Sabapathy K, Lane DP. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others. Nat Rev Clin Oncol. 2018;15(1):13–30. doi: 10.1038/nrclinonc.2017.151</mixed-citation><mixed-citation xml:lang="ru">Sabapathy K., Lane D. P. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others // Nat Rev Clin Oncol. 2018. Vol. 15, N 1. P. 13–30. doi: 10.1038/nrclinonc.2017.151</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol. 1995;5(8):931–936. doi: 10.1016/s0960-9822(95)00183-7</mixed-citation><mixed-citation xml:lang="ru">Armstrong J.F., Kaufman M. H., Harrison D. J., Clarke A. R. High-frequency developmental abnormalities in p53-deficient mice // Curr Biol. 1995. Vol. 5, N 8. P. 931–936. doi: 10.1016/s0960-9822(95)00183-7</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Kastyro IV, Kostyaeva MG, Severin’ AE. Criteria for stress reactions in simulation of septoplasty in rats: parameters of heart rate variability. Head and neck. Russian Journal. 2022;10(S2S1):5–7. EDN: WYBQRG doi: 10.25792/HN.2022.10.2.S1.5-7</mixed-citation><mixed-citation xml:lang="ru">Кастыро И.В., Костяева М. Г., Северин А. Е., и др. Критерии стрессорных реакций при моделировании септопластики у крыс: параметры вариабельности сердечного ритма // Head and Neck / Голова и шея. Российское издание. Журнал Общероссийской общественной организации «Федерация специалистов по лечению заболеваний головы и шеи». 2022. Т. 10, № S2S1. С. 5–7. EDN: WYBQRG doi: 10.25792/HN.2022.10.2.S1.5-7</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Dittmer D, Pati S, Zambetti G, et al. Gain of function mutations in p53. Nat Genet. 1993;4(1):42–46. doi: 10.1038/ng0593-42</mixed-citation><mixed-citation xml:lang="ru">Dittmer D., Pati S., Zambetti G., et al. Gain of function mutations in p53 // Nat Genet. 1993. Vol. 4, N 1. P. 42–46. doi: 10.1038/ng0593-42</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Miller FD, Kaplan DR. To die or not to die: neurons and p63. Cell Cycle. 2007;6(3):312–317. doi: 10.4161/cc.6.3.3795</mixed-citation><mixed-citation xml:lang="ru">Miller F.D., Kaplan D. R. To die or not to die: neurons and p63 // Cell Cycle. 2007. Vol. 6, N 3. P. 312–317. doi: 10.4161/cc.6.3.3795</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Torshin VI, Kastyro IV, Reshetov IV, et al. The relationship between p53-positive neurons and dark neurons in the hippocampus of rats after surgical interventions on the nasal septum. Dokl Biochem Biophys. 2022;502(1):30–35. doi: 10.1134/S1607672922010094</mixed-citation><mixed-citation xml:lang="ru">Torshin V.I., Kastyro I. V., Reshetov I. V., et al. The Relationship between p53-positive neurons and dark neurons in the hippocampus of rats after surgical interventions on the nasal septum // Dokl Biochem Biophys. 2022. Vol. 502, N 1. P. 30–35. doi: 10.1134/S1607672922010094</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">Kempermann G, Kuhn HG, Gage FH. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci U S A. 1997;94(19):10409–10414. doi: 10.1073/pnas.94.19.10409</mixed-citation><mixed-citation xml:lang="ru">Kempermann G., Kuhn H. G., Gage F. H. Genetic influence on neurogenesis in the dentate gyrus of adult mice // Proc Natl Acad Sci U S A. 1997. Vol. 94, N 19. P. 10409–10414. doi: 10.1073/pnas.94.19.10409</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Liu H, Jia D, Li A, et al. p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1. Stem Cells Dev. 2013;22(6):913–927. doi: 10.1089/scd.2012.0370</mixed-citation><mixed-citation xml:lang="ru">Liu H., Jia D., Li A., et al. p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1 // Stem Cells Dev. 2013. Vol. 22, N 6. P. 913–927. doi: 10.1089/scd.2012.0370</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Forsberg K, Wuttke A, Quadrato G, et al. The tumor suppressor p53 fine-tunes reactive oxygen species levels and neurogenesis via PI3 kinase signaling. J Neurosci. 2013;33(36):14318–14330. doi: 10.1523/JNEUROSCI.1056-13.2013</mixed-citation><mixed-citation xml:lang="ru">Forsberg K., Wuttke A., Quadrato G., et al. The tumor suppressor p53 fine-tunes reactive oxygen species levels and neurogenesis via PI3 kinase signaling // J Neurosci. 2013. Vol. 33, N 36. P. 14318–14330. doi: 10.1523/JNEUROSCI.1056-13.2013</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Z, Zhang C, Skamagki M, et al. Elevated p53 activities restrict differentiation potential of microrna-deficient pluripotent stem cells. Stem Cell Reports. 2017;9(5):1604–1617. doi: 10.1016/j.stemcr.2017.10.006</mixed-citation><mixed-citation xml:lang="ru">Liu Z., Zhang C., Skamagki M., et al. Elevated p53 activities restrict differentiation potential of microRNA-deficient pluripotent stem cells // Stem Cell Reports. 2017. Vol. 9, N 5. P. 1604–1617. doi: 10.1016/j.stemcr.2017.10.006</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y, Chen Y, Lu X, et al. SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway. Mol Biol Cell. 2012;23(23):4506–4514. doi: 10.1091/mbc.E12-05-0362</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Chen Y., Lu X., et al. SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway // Mol Biol Cell. 2012. Vol. 23, N 23. P. 4506–4514. doi: 10.1091/mbc.E12-05-0362</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">Stavridis MP, Lunn JS, Collins BJ, Storey KG. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification. Development. 2007;134(16):2889–2894. doi: 10.1242/dev.02858</mixed-citation><mixed-citation xml:lang="ru">Stavridis M.P., Lunn J. S., Collins B. J., Storey K. G. A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification // Development. 2007. Vol. 134, N 16. P. 2889–2894. doi: 10.1242/dev.02858</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">Marin Navarro Navarro A, Pronk RJ, van der Geest AT, et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 2020;11(1):52. doi: 10.1038/s41419-019-2208-7</mixed-citation><mixed-citation xml:lang="ru">Marin Navarro A., Pronk R. J., van der Geest A. T., et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids // Cell Death Dis. 2020. Vol. 11, N 1. P. 52. doi: 10.1038/s41419-019-2208-7</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun. 2005;331(3):761–777. doi: 10.1016/j.bbrc.2005.03.149</mixed-citation><mixed-citation xml:lang="ru">Culmsee C., Mattson M. P. p53 in neuronal apoptosis // Biochem Biophys Res Commun. 2005. Vol. 331, N 3. P. 761–777. doi: 10.1016/j.bbrc.2005.03.149</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Zhao J, Dong Y, Chen X, et al. p53 Inhibition protects against neuronal ischemia/reperfusion injury by the p53/PRAS40/mTOR pathway. Oxid Med Cell Longev. 2021;2021:4729465. doi: 10.1155/2021/4729465</mixed-citation><mixed-citation xml:lang="ru">Zhao J., Dong Y., Chen X., et al. p53 inhibition protects against neuronal ischemia/reperfusion injury by the p53/PRAS40/mTOR pathway // Oxid Med Cell Longev. 2021. Vol. 2021. P. 4729465. doi: 10.1155/2021/4729465</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">Xiao Z, Shen D, Lan T, et al. Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice. Redox Biol. 2022;50:102256. doi: 10.1016/j.redox.2022.102256</mixed-citation><mixed-citation xml:lang="ru">Xiao Z., Shen D., Lan T., et al. Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice // Redox Biol. 2022. Vol. 50. P. 102256. doi: 10.1016/j.redox.2022.102256</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042</mixed-citation><mixed-citation xml:lang="ru">Dixon S.J., Lemberg K. M., Lamprecht M. R., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death // Cell. 2012. Vol. 149, N 5. P. 1060–1072. doi: 10.1016/j.cell.2012.03.042</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 2015;6:524–551. doi: 10.1016/j.redox.2015.08.020</mixed-citation><mixed-citation xml:lang="ru">Granger D.N., Kvietys P. R. Reperfusion injury and reactive oxygen species: the evolution of a concept // Redox Biol. 2015. Vol. 6. P. 524–551. doi: 10.1016/j.redox.2015.08.020</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57–62. doi: 10.1038/nature14344</mixed-citation><mixed-citation xml:lang="ru">Jiang L., Kon N., Li T., et al. Ferroptosis as a p53-mediated activity during tumour suppression // Nature. 2015. Vol. 520, N 7545. P. 57–62. doi: 10.1038/nature14344</mixed-citation></citation-alternatives></ref><ref id="B68"><label>68.</label><citation-alternatives><mixed-citation xml:lang="en">Maor-Nof M, Shipony Z, Lopez-Gonzalez R, et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell. 2021;184(3):689–708.e20. doi: 10.1016/j.cell.2020.12.025</mixed-citation><mixed-citation xml:lang="ru">Maor-Nof M., Shipony Z., Lopez-Gonzalez R., et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR) // Cell. 2021. Vol. 184, N 3. P. 689–708. doi: 10.1016/j.cell.2020.12.025</mixed-citation></citation-alternatives></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">Xu S, Li X, Wang Y. Regulation of the p53 mediated ferroptosis signaling pathway in cerebral ischemia stroke (review). Exp Ther Med. 2023;25(3):113. doi: 10.3892/etm.2023.11812</mixed-citation><mixed-citation xml:lang="ru">Xu S., Li X., Wang Y. Regulation of the p53mediated ferroptosis signaling pathway in cerebral ischemia stroke (review) // Exp Ther Med. 2023. Vol. 25, N 3. P. 113. doi: 10.3892/etm.2023.11812</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><citation-alternatives><mixed-citation xml:lang="en">Dragunova SG, Kosyreva TF, Severin AE. The effect of simulating sinus lifting and septoplasty on changes in the sympathetic and parasympathetic nervous systems in rats. Head and neck. Russian Journal. 2021;9(3):43–49. EDN: KBQHML doi: 10.25792/HN.2021.9.3.43-49</mixed-citation><mixed-citation xml:lang="ru">Драгунова С.Г., Косырева Т. Ф., Северин А. Е., и др. Эффект моделирования синус-лифтинга и септопластики на изменения симпатической и парасимпатической нервных систем у крыс // Head and Neck / Голова и шея. Российское издание. Журнал Общероссийской общественной организации «Федерация специалистов по лечению заболеваний головы и шеи». 2021. Т. 9, № 3. С. 43–49. EDN: KBQHML doi: 10.25792/HN.2021.9.3.43-49</mixed-citation></citation-alternatives></ref><ref id="B71"><label>71.</label><citation-alternatives><mixed-citation xml:lang="en">Kastyro IV, Mikhalskaia PV, Khamidulin GV, et al. Expression of the P53 protein and morphological changes in neurons in the pyramidal layer of the hippocampus after simulation of surgical interventions in the nasal cavity in rats. Cell Physiol Biochem. 2023;57(1):23–33. doi: 10.33594/000000605</mixed-citation><mixed-citation xml:lang="ru">Kastyro I.V., Mikhalskaia P. V., Khamidulin G. V., et al. Expression of the P53 protein and morphological changes in neurons in the pyramidal layer of the hippocampus after simulation of surgical interventions in the nasal cavity in rats // Cell Physiol Biochem. 2023. Vol. 57, N 1. P. 23–33. doi: 10.33594/000000605</mixed-citation></citation-alternatives></ref><ref id="B72"><label>72.</label><citation-alternatives><mixed-citation xml:lang="en">Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. doi: 10.1101/cshperspect.a028035</mixed-citation><mixed-citation xml:lang="ru">Dugger B.N., Dickson D. W. Pathology of neurodegenerative diseases // Cold Spring Harb Perspect Biol. 2017. Vol. 9, N 7. P. a028035. doi: 10.1101/cshperspect.a028035</mixed-citation></citation-alternatives></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">Small SA, Perera GM, DeLaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease. Ann Neurol. 1999;45(4):466–472. doi: 10.1002/1531-8249(199904)45:4&lt;466::AID-ANA8&gt;3.0.CO;2-Q</mixed-citation><mixed-citation xml:lang="ru">Small S.A., Perera G. M., DeLaPaz R., et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease // Ann Neurol. 1999. Vol. 45, N 4. P. 466–472. doi: 10.1002/1531-8249(199904)45:4&lt;466::AID-ANA8&gt;3.0.CO;2-Q</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">Li LB, Chai R, Zhang S, et al. Iron exposure and the cellular mechanisms linked to neuron degeneration in adult mice. Cells. 2019;8(2):198. doi: 10.3390/cells8020198</mixed-citation><mixed-citation xml:lang="ru">Li L.B., Chai R., Zhang S., et al. Iron exposure and the cellular mechanisms linked to neuron degeneration in adult mice // Cells. 2019. Vol. 8, N 2. P. 198. doi: 10.3390/cells8020198</mixed-citation></citation-alternatives></ref><ref id="B75"><label>75.</label><citation-alternatives><mixed-citation xml:lang="en">Talebi M, Talebi M, Kakouri E, et al. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases. Int J Biol Macromol. 2021;172:93–103. doi: 10.1016/j.ijbiomac.2021.01.042</mixed-citation><mixed-citation xml:lang="ru">Talebi M., Talebi M., Kakouri E., et al. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases // Int J Biol Macromol. 2021. Vol. 172. P. 93–103. doi: 10.1016/j.ijbiomac.2021.01.042</mixed-citation></citation-alternatives></ref><ref id="B76"><label>76.</label><citation-alternatives><mixed-citation xml:lang="en">Qi Y, Cheng X, Jing H, et al. Effect of Alpinia oxyphylla-Schisandra chinensis herb pair on inflammation and apoptosis in Alzheimer’s disease mice model. J Ethnopharmacol. 2019;237:28–38. doi: 10.1016/j.jep.2019.03.029</mixed-citation><mixed-citation xml:lang="ru">Qi Y., Cheng X., Jing H., et al. Effect of Alpinia oxyphylla-Schisandra chinensis herb pair on inflammation and apoptosis in Alzheimer’s disease mice model // J Ethnopharmacol. 2019. Vol. 237. P. 28–38. doi: 10.1016/j.jep.2019.03.029</mixed-citation></citation-alternatives></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577–1590. doi: 10.1016/S0140-6736(20)32205-4</mixed-citation><mixed-citation xml:lang="ru">Scheltens P., De Strooper B., Kivipelto M., et al. Alzheimer’s disease // Lancet. 2021. Vol. 397, N 10284. P. 1577–1590. doi: 10.1016/S0140-6736(20)32205-4</mixed-citation></citation-alternatives></ref><ref id="B78"><label>78.</label><citation-alternatives><mixed-citation xml:lang="en">Li H, Zhang Z, Li H, Pan X, Wang Y. New insights into the roles of p53 in central nervous system diseases. Int J Neuropsychopharmacol. 2023;26(7):465–473. doi: 10.1093/ijnp/pyad030</mixed-citation><mixed-citation xml:lang="ru">Li H., Zhang Z., Li H., et al. New insights into the roles of p53 in central nervous system diseases // Int J Neuropsychopharmacol. 2023. Vol. 26, N 7. P. 465–473. doi: 10.1093/ijnp/pyad030</mixed-citation></citation-alternatives></ref><ref id="B79"><label>79.</label><citation-alternatives><mixed-citation xml:lang="en">Abate G, Frisoni GB, Bourdon JC, et al. The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease. Alzheimers Res Ther. 2020;12(1):160. doi: 10.1186/s13195-020-00732-0</mixed-citation><mixed-citation xml:lang="ru">Abate G., Frisoni G. B., Bourdon J. C., et al. The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease // Alzheimers Res Ther. 2020. Vol. 12, N 1. P. 160. doi: 10.1186/s13195-020-00732-0</mixed-citation></citation-alternatives></ref><ref id="B80"><label>80.</label><citation-alternatives><mixed-citation xml:lang="en">Ribe EM, Jean YY, Goldstein RL, et al. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD. Biochem J. 2012;444(3):591–599. doi: 10.1042/BJ20111588</mixed-citation><mixed-citation xml:lang="ru">Ribe E.M., Jean Y. Y., Goldstein R. L., et al. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD // Biochem J. 2012. Vol. 444, N 3. P. 591–599. doi: 10.1042/BJ20111588</mixed-citation></citation-alternatives></ref><ref id="B81"><label>81.</label><citation-alternatives><mixed-citation xml:lang="en">Volik PI, Kopeina GS, Zhivotovsky B, Zamaraev AV. Total recall: the role of PIDDosome components in neurodegeneration. Trends Mol Med. 2023;29(12):996–1013. doi: 10.1016/j.molmed.2023.08.008</mixed-citation><mixed-citation xml:lang="ru">Volik P.I., Kopeina G. S., Zhivotovsky B., Zamaraev A. V. Total recall: the role of PIDDosome components in neurodegeneration // Trends Mol Med. 2023. Vol. 29, N 12. P. 996–1013. doi: 10.1016/j.molmed.2023.08.008</mixed-citation></citation-alternatives></ref><ref id="B82"><label>82.</label><citation-alternatives><mixed-citation xml:lang="en">Raza C, Anjum R, Shakeel NUA. Parkinson’s disease: mechanisms, translational models and management strategies. Life Sci. 2019;226:77–90. doi: 10.1016/j.lfs.2019.03.057</mixed-citation><mixed-citation xml:lang="ru">Raza C., Anjum R., Shakeel N.U.A. Parkinson’s disease: mechanisms, translational models and management strategies // Life Sci. 2019. Vol. 226. P. 77–90. doi: 10.1016/j.lfs.2019.03.057</mixed-citation></citation-alternatives></ref><ref id="B83"><label>83.</label><citation-alternatives><mixed-citation xml:lang="en">Luo Q, Sun W, Wang YF, et al. Association of p53 with neurodegeneration in Parkinson’s disease. Parkinsons Dis. 2022;2022:6600944. doi: 10.1155/2022/6600944</mixed-citation><mixed-citation xml:lang="ru">Luo Q., Sun W., Wang Y. F., et al. Association of p53 with neurodegeneration in Parkinson’s disease // Parkinsons Dis. 2022. Vol. 2022. P. 6600944. doi: 10.1155/2022/6600944</mixed-citation></citation-alternatives></ref><ref id="B84"><label>84.</label><citation-alternatives><mixed-citation xml:lang="en">Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129–142. doi: 10.1016/S0140-6736(20)31179-X</mixed-citation><mixed-citation xml:lang="ru">Campbell B.C.V., Khatri P. Stroke // Lancet. 2020. Vol. 396, N 10244. P. 129–142. doi: 10.1016/S0140-6736(20)31179-X</mixed-citation></citation-alternatives></ref><ref id="B85"><label>85.</label><citation-alternatives><mixed-citation xml:lang="en">Almeida A, Sánchez-Morán I, Rodríguez C. Mitochondrial-nuclear p53 trafficking controls neuronal susceptibility in stroke. IUBMB Life. 2021;73(3):582–591. doi: 10.1002/iub.2453</mixed-citation><mixed-citation xml:lang="ru">Almeida A., Sánchez-Morán I., Rodríguez C. Mitochondrial-nuclear p53 trafficking controls neuronal susceptibility in stroke // IUBMB Life. 2021. Vol. 73, N 3. P. 582–591. doi: 10.1002/iub.2453</mixed-citation></citation-alternatives></ref><ref id="B86"><label>86.</label><citation-alternatives><mixed-citation xml:lang="en">Ashraf A, So PW. Spotlight on ferroptosis: iron-dependent cell death in Alzheimer’s disease. Front Aging Neurosci. 2020;12:196. doi: 10.3389/fnagi.2020.00196</mixed-citation><mixed-citation xml:lang="ru">Ashraf A., So P. W. Spotlight on ferroptosis: iron-dependent cell death in Alzheimer’s disease // Front Aging Neurosci. 2020. Vol. 12. P. 196. doi: 10.3389/fnagi.2020.00196</mixed-citation></citation-alternatives></ref><ref id="B87"><label>87.</label><citation-alternatives><mixed-citation xml:lang="en">Kostyaeva M, Dragunova S, Zindovic N, et al. Pathological changes in traumatization of upper jaw under the conditions of sinus lifting simulation in rats. Journal of Clinical Physiology and Pathology (JCPP). 2023;2(1):4–10.</mixed-citation><mixed-citation xml:lang="ru">Kostyaeva M., Dragunova S., Zindovic N., et al. Pathological changes in traumatization of upper jaw under the conditions of sinus lifting simulation in rats // Journal of Clinical Physiology and Pathology (JCPP). 2023. Vol. 2, N 1. P. 4–10.</mixed-citation></citation-alternatives></ref><ref id="B88"><label>88.</label><citation-alternatives><mixed-citation xml:lang="en">Merlo P, Frost B, Peng S, et al. p53 prevents neurodegeneration by regulating synaptic genes. Proc Natl Acad Sci U S A. 2014;111(50):18055–18060. doi: 10.1073/pnas.1419083111</mixed-citation><mixed-citation xml:lang="ru">Merlo P., Frost B., Peng S., et al. p53 prevents neurodegeneration by regulating synaptic genes // Proc Natl Acad Sci U S A. 2014. Vol. 111, N 50. P. 18055–18060. doi: 10.1073/pnas.1419083111</mixed-citation></citation-alternatives></ref><ref id="B89"><label>89.</label><citation-alternatives><mixed-citation xml:lang="en">Kastyro IV, Hamidulin GV, Dyachenko YuE, et al. Analysis of p53 protein expression and formation of dark neurons in the hippocampus of rats during septoplasty modeling. Russian Rhinology. 2023;31(1):27–36. EDN: KYBRDQ doi: 10.17116/rosrino20233101127</mixed-citation><mixed-citation xml:lang="ru">Кастыро И.В., Хамидулин Г. В., Дьяченко Ю. Е., и др. Исследование экспрессии белка p53 и образования темных нейронов в гиппокампе у крыс при моделировании септопластики // Российская ринология. 2023. Т. 31, № 1. С. 27–36. EDN: KYBRDQ doi: 10.17116/rosrino20233101127</mixed-citation></citation-alternatives></ref><ref id="B90"><label>90.</label><citation-alternatives><mixed-citation xml:lang="en">Haider S, Naqvi F, Batool Z, et al. Decreased hippocampal 5-HT and DA levels following sub-chronic exposure to noise stress: impairment in both spatial and recognition memory in male rats. Sci Pharm. 2012;80(4):1001–1011. doi: 10.3797/scipharm.1207-15</mixed-citation><mixed-citation xml:lang="ru">Haider S., Naqvi F., Batool Z., et al. Decreased hippocampal 5-HT and DA levels following sub-chronic exposure to noise stress: impairment in both spatial and recognition memory in male rats // Sci Pharm. 2012. Vol. 80, N 4. P. 1001–1011. doi: 10.3797/scipharm.1207-15</mixed-citation></citation-alternatives></ref><ref id="B91"><label>91.</label><citation-alternatives><mixed-citation xml:lang="en">Kastyro IV, Reshetov IV, Khamidulin GV, et al. Influence of surgical trauma in the nasal cavity on the expression of p53 protein in the hippocampus of rats. Dokl Biochem Biophys. 2021;497(1):99–103. doi: 10.1134/S160767292102006X</mixed-citation><mixed-citation xml:lang="ru">Kastyro I.V., Reshetov I. V., Khamidulin G. V., et al. Influence of surgical trauma in the nasal cavity on the expression of p53 protein in the hippocampus of rats // Dokl Biochem Biophys. 2021. Vol. 497, N 1. P. 99–103. doi: 10.1134/S160767292102006X</mixed-citation></citation-alternatives></ref><ref id="B92"><label>92.</label><citation-alternatives><mixed-citation xml:lang="en">Csordás A, Mázló M, Gallyas F. Recovery versus death of “dark” (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations. Acta Neuropathol. 2003;106(1):37–49. doi: 10.1007/s00401-003-0694-1</mixed-citation><mixed-citation xml:lang="ru">Csordás A., Mázló M., Gallyas F. Recovery versus death of “dark” (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations // Acta Neuropathol. 2003. Vol. 106, N 1. P. 37–49. doi: 10.1007/s00401-003-0694-1</mixed-citation></citation-alternatives></ref><ref id="B93"><label>93.</label><citation-alternatives><mixed-citation xml:lang="en">Kastyro IV, Kostyaeva MG, Korolev AG. Influence of simulation of septoplasty and surgical injury of the upper jaw on changes in the noradrenergic system of the hippocampal formation. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2023;29(2):24–35. EDN: EVRJWG doi: 10.33848/foliorl23103825-2023-29-2-24-35</mixed-citation><mixed-citation xml:lang="ru">Кастыро И.В., Костяева М. Г., Королев А. Г., и др. Влияние моделирования септопластики и хирургического повреждения верхней челюсти на изменения норадренергической системы гиппокампальной формации // Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2023. Т. 29, № 2. С. 24–35. EDN: EVRJWG doi: 10.33848/foliorl23103825-2023-29-2-24-35</mixed-citation></citation-alternatives></ref></ref-list></back></article>
